PATENT CLAIM ANALYSIS

Application Number: 16079868
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "04400A"]

Abstract:
Aberrantly expressed piRNAs, genetically associated piRNAs and their relationship with cancer risk and severity are provided. Compositions and methods of using piRNA for treating cancer are provided. Methods of diagnosing subjects and determining the efficacy of active agents for treating cancer are also provided. Methods of correlating variant piRNA to cancer are also disclosed.

Claim (Index 17):
The method of  claim 16 , wherein piR-31637 is underexpressed in the cancer relative to normal tissue.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 96.0
- Lexical Diversity: 1.63889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13470233', '15313555', '14112296', '14020811', '15422725']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7582996500139753
- 35 USC 102 Novelty (BERT): 0.5161772473213063
- Combined Prediction Score: 0.7340874097447084
- Mean Citation Score: 233.341736
- Max Citation Score: 247.30536
- Similarity Product: 142.3426337142563

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test